Naturhouse Health Statistics

Total Valuation

LON:0R9G has a market cap or net worth of GBP 89.23 million. The enterprise value is 75.28 million.

Market Cap	89.23M
Enterprise Value	75.28M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	Apr 3, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	13.12M

Valuation Ratios

The trailing PE ratio is 10.94.

PE Ratio	10.94
Forward PE	n/a
PS Ratio	2.18
PB Ratio	3.41
P/TBV Ratio	3.45
P/FCF Ratio	9.62
P/OCF Ratio	9.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.75, with an EV/FCF ratio of 8.11.

EV / Earnings	9.23
EV / Sales	1.79
EV / EBITDA	5.75
EV / EBIT	6.50
EV / FCF	8.11

Financial Position

The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.13.

Current Ratio	4.36
Quick Ratio	3.61
Debt / Equity	0.13
Debt / EBITDA	0.29
Debt / FCF	0.38
Interest Coverage	22.04

Financial Efficiency

Return on equity (ROE) is 31.65% and return on invested capital (ROIC) is 22.92%.

Return on Equity (ROE)	31.65%
Return on Assets (ROA)	17.96%
Return on Invested Capital (ROIC)	22.92%
Return on Capital Employed (ROCE)	36.36%
Revenue Per Employee	213,995
Profits Per Employee	42,704
Employee Count	191
Asset Turnover	1.08
Inventory Turnover	4.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.10% in the last 52 weeks. The beta is 0.60, so LON:0R9G's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+2.10%
50-Day Moving Average	1.75
200-Day Moving Average	1.74
Relative Strength Index (RSI)	50.36
Average Volume (20 Days)	29

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0R9G had revenue of GBP 40.87 million and earned 8.16 million in profits. Earnings per share was 0.13.

Revenue	40.87M
Gross Profit	29.17M
Operating Income	10.86M
Pretax Income	11.20M
Net Income	8.16M
EBITDA	11.18M
EBIT	10.86M
Earnings Per Share (EPS)	0.13

Full Income Statement

Balance Sheet

The company has 17.10 million in cash and 3.53 million in debt, giving a net cash position of 13.57 million.

Cash & Cash Equivalents	17.10M
Total Debt	3.53M
Net Cash	13.57M
Net Cash Per Share	n/a
Equity (Book Value)	26.20M
Book Value Per Share	0.44
Working Capital	17.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.56 million and capital expenditures -279,516, giving a free cash flow of 9.28 million.

Operating Cash Flow	9.56M
Capital Expenditures	-279,516
Free Cash Flow	9.28M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.38%, with operating and profit margins of 26.58% and 19.96%.

Gross Margin	71.38%
Operating Margin	26.58%
Pretax Margin	27.40%
Profit Margin	19.96%
EBITDA Margin	27.35%
EBIT Margin	26.58%
FCF Margin	22.70%

Dividends & Yields

This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 8.03%.

Dividend Per Share	0.14
Dividend Yield	8.03%
Dividend Growth (YoY)	30.41%
Years of Dividend Growth	1
Payout Ratio	121.67%
Buyback Yield	n/a
Shareholder Yield	8.03%
Earnings Yield	9.14%
FCF Yield	10.40%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R9G has an Altman Z-Score of 8.45.

Altman Z-Score	8.45
Piotroski F-Score	n/a